Advantest Corporation (Kabushiki Kaisha Advantest) ADS Press Releases

ATE 
$13.2
*  
0.13
0.98%
Get ATE Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ATE now
Exchange: NYSE
Industry: Technology
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Antibe Therapeutics Reports Q3 2015 Interim Financial and Operating Results and Director Resignation
2/27/2015 9:06:00 PM - Business Wire


W2BI, Inc. to Demonstrate Suite of New Wireless Device Test Automation Products at Mobile World Congress in Barcelona, March 2-5, 2015
2/25/2015 4:30:00 PM - Business Wire


Antibe Therapeutics Announces No Material Change
2/4/2015 7:45:00 PM - Business Wire


W2BI, Inc. to Demonstrate Suite of New Wireless Device Test Automation Products at Mobile World Congress in Barcelona, March 2-5, 2015
2/3/2015 10:00:00 AM - Business Wire


Media Alert: Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6
1/28/2015 3:05:00 AM - Market Wire
▲14.19 % Price Change since this news event. The Volume Ratio is 0.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Antibe Therapeutics Suspends Its Phase I Clinical Trial Due to Safety Concerns
1/16/2015 7:45:00 AM - Business Wire


Advantest Opens Registration for VOICE 2015 Developer Conference May 12-14
1/12/2015 3:05:00 AM - Market Wire


Advantest Opens Registration for VOICE 2015 Developer Conference May 12-14
1/12/2015 3:05:00 AM - Market Wire
▲11.58 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Antibe Therapeutics Announces Appointment of Canadian Rheumatologist J. Carter Thorne to Its Clinical Advisory Board
12/18/2014 7:45:00 AM - Business Wire


Jacobs Selected by BP as Strategic Supplier
12/18/2014 7:45:00 AM - Business Wire


Antibe Therapeutics Announces Appointment of US-Based Investor Relations Consultant
12/16/2014 7:45:00 AM - Business Wire


Advantest to Exhibit at SEMICON Japan 2014 in Tokyo, Japan December 3-5
12/2/2014 3:05:00 AM - Market Wire
▲9.82 % Price Change since this news event. The Volume Ratio is 4.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day